Maria Vaysberg, Ph.D. - Publications

Affiliations: 
2008 Stanford University, Palo Alto, CA 
Area:
Cell Biology, Molecular Biology, Virology Biology

14 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2013 Hatton O, Lambert SL, Phillips LK, Vaysberg M, Natkunam Y, Esquivel CO, Krams SM, Martinez OM. Syk-induced phosphatidylinositol-3-kinase activation in Epstein-Barr virus posttransplant lymphoproliferative disorder. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 13: 883-90. PMID 23398911 DOI: 10.1111/Ajt.12137  0.776
2012 Hatton O, Phillips LK, Vaysberg M, Hurwich J, Krams SM, Martinez OM. Syk activation of phosphatidylinositol 3-kinase/Akt prevents HtrA2-dependent loss of X-linked inhibitor of apoptosis protein (XIAP) to promote survival of epstein-barr virus+ (EBV+) B cell lymphomas (Journal of Biological Chemistry (2011) 286, (37368-37378) DOI: 10.1074/jbc.A111.255125) Journal of Biological Chemistry. 287: 13557. DOI: 10.1074/jbc.A111.255125  0.768
2011 Hatton O, Phillips LK, Vaysberg M, Hurwich J, Krams SM, Martinez OM. Syk activation of phosphatidylinositol 3-kinase/Akt prevents HtrA2-dependent loss of X-linked inhibitor of apoptosis protein (XIAP) to promote survival of Epstein-Barr virus+ (EBV+) B cell lymphomas. The Journal of Biological Chemistry. 286: 37368-78. PMID 21908615 DOI: 10.1074/Jbc.M111.255125  0.779
2010 Rodriguez HM, Vaysberg M, Mikels A, McCauley S, Velayo AC, Garcia C, Smith V. Modulation of lysyl oxidase-like 2 enzymatic activity by an allosteric antibody inhibitor Journal of Biological Chemistry. 285: 20964-20974. PMID 20439985 DOI: 10.1074/Jbc.M109.094136  0.32
2010 Hatton O, Lambert SL, Vaysberg M, Krams SM, Esquivel CO, Martinez OM. POSITIVE AND NEGATIVE REGULATION OF THE EPSTEIN BARR VIRUS (EBV)+ B CELL LYMPHOMA MICROENVIRONMENT BY SYK TYROSINE KINASE Transplantation Journal. 90: 703. DOI: 10.1097/00007890-201007272-01354  0.795
2009 Vaysberg M, Lambert SL, Krams SM, Martinez OM. Activation of the JAK/STAT pathway in Epstein Barr virus+-associated posttransplant lymphoproliferative disease: role of interferon-gamma. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 9: 2292-302. PMID 19656130 DOI: 10.1111/J.1600-6143.2009.02781.X  0.726
2008 Vaysberg M, Hatton O, Lambert SL, Snow AL, Wong B, Krams SM, Martinez OM. Tumor-derived variants of Epstein-Barr virus latent membrane protein 1 induce sustained Erk activation and c-Fos. The Journal of Biological Chemistry. 283: 36573-85. PMID 18986987 DOI: 10.1074/Jbc.M802968200  0.765
2008 Martinez O, Vaysberg M, Wong B, Lambert S, Krams S, Esquivel C. PTLD DERIVED TUMOR VARIANTS OF EBV LATENT MEMBRANE PROTEIN 1 INDUCE SUSTAINED ERK ACTIVATION AND CFOS INDUCTION Transplantation. 86: 132. DOI: 10.1097/01.Tp.0000332483.11893.9C  0.622
2008 Hatton O, Lambert S, Vaysberg M, Sharman J, Krams SM, Esquivel CO, Martinez OM. SYK, A NOVEL THERAPEUTIC TARGET FOR PTLD, DRIVES EPSTEIN BARR VIRUS (EBV)+ B CELL LYMPHOMA GROWTH AND SURVIVAL THROUGH ACTIVATION OF THE PI3K/AKT PATHWAY Transplantation. 86: 282. DOI: 10.1097/01.Tp.0000332036.17315.6A  0.805
2008 Martinez O, Vaysberg M, Lambert S, Kra S, Esquivel C. EPSTEIN BARR VIRUS ENCODED LATENT MEMBRANE PROTEIN 1 ACTIVATES THE JAK/STAT PATHWAY INDIRECTLY THROUGH PRODUCTION OF IFN-G Transplantation. 86: 720. DOI: 10.1097/01.Tp.0000330547.19816.Ce  0.603
2007 Vaysberg M, Balatoni CE, Nepomuceno RR, Krams SM, Martinez OM. Rapamycin inhibits proliferation of Epstein-Barr virus-positive B-cell lymphomas through modulation of cell-cycle protein expression. Transplantation. 83: 1114-21. PMID 17452903 DOI: 10.1097/01.Tp.0000260142.38619.9C  0.719
2006 Snow AL, Vaysberg M, Krams SM, Martinez OM. EBV B lymphoma cell lines from patients with post-transplant lymphoproliferative disease are resistant to TRAIL-induced apoptosis. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 6: 976-85. PMID 16611333 DOI: 10.1111/J.1600-6143.2006.01295.X  0.745
2004 Vaysberg M, Balatoni CE, Nepomuceno RR, Krams SM, Martinez OM. RAPAMYCIN INHIBITS EPSTEIN BARR VIRUS+ B CELL LYMPHOMA PROLIFERATION THROUGH MODULATION OF CELL CYCLE PROTEIN EXPRESSION. Transplantation. 78: 76. DOI: 10.1097/00007890-200407271-00207  0.724
2004 Snow AL, Vaysberg M, Krams SM, Martinez OM. EBV+ B CELL LYMPHOMAS ASSOCIATED WITH POST-TRANSPLANT LYMPHOPROLIFERATIVE DISEASE DEMONSTRATE UNIQUE DEFECTS IN TRAIL-INDUCED APOPTOSIS Transplantation. 78: 33. DOI: 10.1097/00007890-200407271-00099  0.745
Show low-probability matches.